Takashi Okuda represents life sciences and technology companies in high-stakes patent disputes. He has experience in both bench and jury trials and translates complex scientific and technical concepts into clear, persuasive cases.
Takashi has extensive IP litigation experience across multiple forums and sectors. He guides multinational companies through every stage of patent disputes, from early investigation and case strategy through trial. He also represents clients in inter partes review (IPR) proceedings before the Patent Trial and Appeal Board.
Fluent in Japanese, Takashi also regularly advises Japanese companies. He works directly with in-house teams and technical personnel to help navigate the US patent litigation system.
Experience
Takashi’s experience at and prior to joining Latham includes representing:
Merck Sharp & Dohme in Hatch-Waxman litigations relating to antiviral drug for CMV
Ascendis in ITC investigation relating to achondroplasia drug
Biogen and Alkermes in Hatch-Waxman litigations relating to multiple sclerosis drug
Philip Morris & Altria in district court litigation relating to e-vapor technologies, securing jury trial win
BASF in district court litigation relating to omega-3 fatty acids, obtaining favorable jury trial outcome in patent infringement suit involving 17 patents
Ricoh in district court litigation relating to semiconductor technology, obtaining favorable settlement
Takeda in numerous Hatch-Waxman litigations relating to its blockbuster anti-ulcer drug
Santen Pharmaceutical, Asahi Glass, and Oak Pharmaceuticals in Hatch-Waxman litigations and IPR proceeding relating to glaucoma drugs, obtaining favorable final decision upholding validity
Latham's Intellectual Property Litigation Practice was honored for securing exceptional trial results this year, including a complete jury trial win for Sarepta Therapeutics and an ITC trial win for Netgear.
Jury deliberated for 45 minutes before returning a complete victory for our client, garage door manufacturer Overhead Door, against competitor Chamberlain Group.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.